Tirzepatide 50MG
$155.00
Tirzepatide 50MG is a 50-milligram format of tirzepatide, a synthetic peptide studied for its dual activity at GIP and GLP 1 receptors. Research has examined tirzepatide in the context of incretin signalling, glucose metabolism pathways, and energy balance regulation. Its sequence incorporates non natural residues and lipidation that are commonly investigated for effects on peptide stability and receptor engagement.
In Stock
Tirzepatide 50MG is a 50-milligram format of tirzepatide, a synthetic dual incretin peptide analogue designed to engage both GIP and GLP 1 receptors. Studies have examined tirzepatide in preclinical and translational research settings involving incretin biology, insulin secretion signalling, and appetite related pathways, with findings typically interpreted alongside diet induced and metabolic disease models.
Tirzepatide is a modified peptide that includes a fatty acid moiety to enable albumin binding, a design approach researchers often investigate for prolonged systemic exposure and altered pharmacokinetics. Work in receptor pharmacology has explored its binding and signalling bias across GIPR and GLP 1R, as well as downstream second messenger responses under controlled laboratory conditions.
- Specification: 50MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Trenbolone Hexahydrobenzyl Carbonate – 100mg/ml, 10ml is a specified format of trenbolone hexahydrobenzyl carbonate, a long ester derivative of trenbolone, a synthetic anabolic androgenic steroid (19 nor testosterone analogue). It is studied analytically in steroid ester profiling, reference standard comparison, and method development using chromatographic and mass spectrometric techniques.
In Stock
Winstrol 50mg/ml 10ml refers to a 50 milligram per millilitre, 10 millilitre format commonly associated with stanozolol, a synthetic anabolic androgenic steroid. In research settings, stanozolol has been examined for its interactions with androgen receptor signaling and anabolic androgenic structure activity relationships. Studies have also used it as a reference compound in analytical and anti doping method development.
In Stock
Masteron Blend Drostanolone Enanthate 150Mg / Drostanolone Propionate 50Mg 200mg/ml 10 ml is a specified blend of two drostanolone esters in a 10 ml format at 200 mg per ml total concentration. Drostanolone is a synthetic androgen derived from dihydrotestosterone that is studied in androgen receptor and steroid ester pharmacology research. Work in analytical settings commonly examines ester composition, stability, and identity using chromatographic and mass spectrometry methods.
In Stock
Winstrol 100mg ml 10ml is a concentration and volume format commonly associated with stanozolol, a synthetic anabolic androgenic steroid derived from dihydrotestosterone. Researchers and analytical labs may examine stanozolol in contexts such as receptor binding assays, metabolic profiling, and method development for detection and quantification.
In Stock
Trenbolone Acetate 75Mg; Trenbolone Enanthate 75Mg; Trenbolone Hexahydrobenzylcarbonate (Parabolan) 75Mg – 200mg/ml, 10 ml is a multi ester trenbolone preparation specified at 200 mg per mL in a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from 19 nortestosterone, and researchers may use it when studying androgen receptor signaling and steroid structure activity relationships. Work in preclinical and analytical settings has examined trenbolone esters for differences in lipophilicity, hydrolysis rates, and detection profiles.
In Stock
Semaglutide 2MG is a 2-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is studied in pharmacology and metabolic research as a long acting incretin mimetic. Researchers examine semaglutide in receptor signaling and glucose homeostasis models.
In Stock
Cagrilintide + Semaglutide 10MG is a 10-milligram peptide pair combining cagrilintide, an amylin analogue, with semaglutide, a GLP-1 receptor agonist peptide. Researchers study these peptides in metabolic research, including appetite signaling and glucose regulation pathways. This paired format is used in experimental designs that examine co-agonism and complementary endocrine signaling.
In Stock
Cagrilintide 5MG is a 5-milligram format of cagrilintide, a long acting amylin analogue peptide engineered for extended receptor activity. Researchers study amylin analogues in the context of metabolic signaling, appetite regulation pathways, and gastric emptying models.
In Stock
Trenbolone Acetate 100Mg; Drostanolone Propionate 100Mg; Testosterone Propionate 100Mg – 300mg/ml, 10ml is a multi compound anabolic androgenic steroid blend specified at 300mg/ml in a 10ml format. Trenbolone acetate is a 19 nor testosterone derivative, while drostanolone and testosterone propionate are DHT derived and testosterone based esters used in androgen research. Researchers may examine combined esterified androgens in models involving receptor binding, anabolic androgenic signaling, and pharmacokinetic comparisons.
In Stock
Superdrol / Methyldrostanolone 50mg/ml, 10ml refers to a defined concentration and volume format of methyldrostanolone, a 17 alpha alkylated synthetic anabolic androgenic steroid related to dihydrotestosterone analogues. Researchers have examined methyldrostanolone in studies of androgen receptor activity and anabolic androgenic structure activity relationships.
In Stock
Cagrilintide 10MG is a 10-milligram format of cagrilintide, a long acting amylin analogue peptide designed to engage amylin receptor pathways. Researchers study cagrilintide in preclinical and translational settings involving appetite signalling, gastric emptying models, and metabolic regulation.
In Stock
Tirzepatide 15MG is a 15-milligram format of tirzepatide, a synthetic peptide studied as a dual agonist at the GIP and GLP 1 receptors. It is of interest in metabolic and endocrine research where incretin signaling is examined. Studies have evaluated tirzepatide in preclinical and clinical settings to better understand receptor bias, signaling kinetics, and downstream biomarker changes.
In Stock
